Literature DB >> 31661322

Recent cocaine use and memory impairment in HIV.

Pavel Y Litvin1, Craig A Siders1,2, Erin N Waite1, Ellen Woo3, Elizabeth Romero4, Jessica Foley5, Mark L Ettenhofer6, Amanda L Gooding6, Steven Castellon4,7, Charles Hinkin4,7, Matthew J Wright1,7.   

Abstract

Both Human Immunodeficiency Virus (HIV) and cocaine use have been associated with impairment in neuropsychological functioning. The high comorbidity between HIV and cocaine use highlights the importance of ascertaining whether there is a compounding effect of cocaine use in individuals with HIV. Among neuropsychological domains impacted by HIV, verbal memory deficits have received substantial attention partly because they have been associated with declines in functional status in HIV positive individuals. We collected California Verbal Learning Test-II data from HIV participants who met lifetime diagnostic criteria of cocaine abuse and/or dependence (HIV/CocDx+, N = 80 & HIV/CocDx-, N = 30, respectively) and those with and without recent cocaine use, which was confirmed by toxicology analysis (HIV/Coc+, N = 56 & HIV/Coc-, N = 57, respectively). The Item Specific Deficit Approach (ISDA) was employed to determine any additional cocaine-associated deficits in encoding, consolidation, and retrieval, which attempts to control for potential confounding factors of memory such as attention. Using conventional methods of evaluating memory profiles, we found that the HIV/Coc + group demonstrated worse learning, immediate and delayed free recall, and recognition in contrast to the HIV/Coc - group; although using the ISDA, we found that encoding was the only significant difference between HIV/Coc + and HIV/Coc-participant, with HIV/Coc - performing better. Our data suggest that for individuals with HIV, cocaine use is associated with a temporary decline in verbal memory, is characterized by greater encoding deficits, and these effects may reduce with abstinence. Clinically, our findings suggest that reduced encoding is the likely contributor to verbal memory decline in HIV/Coc + and these effects are partially reversible-at least to the level of their HIV/Coc - counterparts.

Entities:  

Keywords:  HIV/AIDS; cocaine; memory; neuropsychology; substance use

Year:  2019        PMID: 31661322      PMCID: PMC7188564          DOI: 10.1080/23279095.2019.1683562

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  86 in total

1.  HIV-1, cocaine, and neuropsychological performance in African American men.

Authors:  R S Durvasula; H F Myers; P Satz; E N Miller; H Morgenstern; M A Richardson; G Evans; D Forney
Journal:  J Int Neuropsychol Soc       Date:  2000-03       Impact factor: 2.892

2.  D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry.

Authors:  Alexandra E Kisilevsky; Sean J Mulligan; Christophe Altier; Mircea C Iftinca; Diego Varela; Chao Tai; Lina Chen; Shahid Hameed; Jawed Hamid; Brian A Macvicar; Gerald W Zamponi
Journal:  Neuron       Date:  2008-05-22       Impact factor: 17.173

Review 3.  Does highly active antiretroviral therapy improve neurocognitive function? A systematic review.

Authors:  John A Joska; Hetta Gouse; Robert H Paul; Dan J Stein; Alan J Flisher
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

Review 4.  Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.

Authors:  Shilpa Buch; Honghong Yao; Minglei Guo; Tomohisa Mori; Tsung-Ping Su; John Wang
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-16       Impact factor: 4.147

Review 5.  G protein modulation of voltage-gated calcium channels.

Authors:  Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

Review 6.  NeuroHIV and use of addictive substances.

Authors:  Sulie L Chang; Kaitlyn P Connaghan; Yufeng Wei; Ming D Li
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

7.  Neurocognition in individuals co-infected with HIV and hepatitis C.

Authors:  Charles H Hinkin; Steven A Castellon; Andrew J Levine; Terry R Barclay; Elyse J Singer
Journal:  J Addict Dis       Date:  2008

8.  Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity.

Authors:  C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

9.  Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort.

Authors:  Matthew J Mimiaga; Sari L Reisner; Chris Grasso; Heidi M Crane; Steven A Safren; Mari M Kitahata; Joseph E Schumacher; W Christopher Mathews; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

10.  Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?

Authors:  Jennifer E Iudicello; Erin E Morgan; Assawin Gongvatana; Scott L Letendre; Igor Grant; Steven Paul Woods
Journal:  J Neurovirol       Date:  2014-01-28       Impact factor: 2.643

View more
  2 in total

1.  Impaired verbal memory in individuals living with HIV and cocaine dependence.

Authors:  Sarah E Nigro; Minjie Wu; Anthony C Juliano; T Celeste Napier; Alan L Landay; Audrey L French; Shaolin Yang
Journal:  J Clin Exp Neuropsychol       Date:  2022-07-04       Impact factor: 2.283

2.  Memory in multiple sclerosis: A reappraisal using the item specific deficit approach.

Authors:  Michael R Basso; Douglas Whiteside; Dennis Combs; Steven Paul Woods; Jordan Hoffmeister; Ryan Mulligan; Peter Arnett; Eva Alden; Oliver Tobin
Journal:  Neuropsychology       Date:  2021-02       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.